Article metrics
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – non-biologic treatment and small molecules
THU0143 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analyses of efficacy endpoints by subgroups in a pooled phase 2 and 3 rheumatoid arthritis study population